Zeillinger R - Search Results

1

Expression of mucins and cytokeratins in ovarian cancer cell lines.

Stimpfl M, Schmid BC, Schiebel I, Tong D, Leodolter S, Obermair A, Zeillinger R. Stimpfl M, et al. Among authors: zeillinger r. Cancer Lett. 1999 Oct 18;145(1-2):133-41. doi: 10.1016/s0304-3835(99)00246-3. Cancer Lett. 1999. PMID: 10530781

2

Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.

Kury FD, Schneeberger C, Sliutz G, Kubista E, Salzer H, Medl M, Leodolter S, Swoboda H, Zeillinger R, Spona J. Kury FD, et al. Among authors: zeillinger r. Oncogene. 1990 Sep;5(9):1403-8. Oncogene. 1990. PMID: 1699198

3

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer.

Wiltschke C, Tyl E, Speiser P, Steininger A, Zeillinger R, Kury F, Czerwenka K, Kubista E, Preis P, Krainer M, et al. Wiltschke C, et al. Among authors: zeillinger r. Cancer. 1994 Jan 1;73(1):135-9. doi: 10.1002/1097-0142(19940101)73:1<135::aid-cncr2820730123>3.0.co;2-s. Cancer. 1994. PMID: 7903907

4

Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines.

Zeillinger R, Tantscher E, Schneeberger C, Tschugguel W, Eder S, Sliutz G, Huber JC. Zeillinger R, et al. Breast Cancer Res Treat. 1996;40(2):205-7. doi: 10.1007/BF01806216. Breast Cancer Res Treat. 1996. PMID: 8879687

5

Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR.

Sliutz G, Eder H, Koelbl H, Tempfer C, Auerbach L, Schneeberger C, Kainz C, Zeillinger R. Sliutz G, et al. Among authors: zeillinger r. Breast Cancer Res Treat. 1996;40(3):257-63. doi: 10.1007/BF01806814. Breast Cancer Res Treat. 1996. PMID: 8883968

6

Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.

Obermair A, Kucera E, Mayerhofer K, Speiser P, Seifert M, Czerwenka K, Kaider A, Leodolter S, Kainz C, Zeillinger R. Obermair A, et al. Among authors: zeillinger r. Int J Cancer. 1997 Aug 22;74(4):455-8. doi: 10.1002/(sici)1097-0215(19970822)74:4<455::aid-ijc17>3.0.co;2-8. Int J Cancer. 1997. PMID: 9291439

7

Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples.

Tong D, Schneeberger C, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Anal Biochem. 1997 Sep 5;251(2):173-7. doi: 10.1006/abio.1997.2280. Anal Biochem. 1997. PMID: 9299013

8

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.

Obermair A, Tempfer C, Hefler L, Preyer O, Kaider A, Zeillinger R, Leodolter S, Kainz C. Obermair A, et al. Among authors: zeillinger r. Br J Cancer. 1998 Jun;77(11):1870-4. doi: 10.1038/bjc.1998.311. Br J Cancer. 1998. PMID: 9667661 Free PMC article.

9

Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients.

Obermair A, Speiser P, Reisenberger K, Ullrich R, Czerwenka K, Kaider A, Zeillinger R, Miksche M. Obermair A, et al. Among authors: zeillinger r. Cancer Lett. 1998 Aug 14;130(1-2):69-76. doi: 10.1016/s0304-3835(98)00119-0. Cancer Lett. 1998. PMID: 9751258

10

BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization.

Tong D, Stimpfl M, Reinthaller A, Vavra N, Müllauer-Ertl S, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Clin Chem. 1999 Jul;45(7):976-81. Clin Chem. 1999. PMID: 10388472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters